Francesca Reggiani

6PUBLICATIONS
24CO-AUTHORS
Molecular targetsPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Cancer cell biology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Mar 23, 2024
BET inhibitors drive Natural Killer activation in non-small cell lung cancer via BRD4 and SMAD3.

Francesca Reggiani, Giovanna Talarico, Giulia Gobbi

|Oct 19, 2023
Spatial Distribution of Immune Cells Drives Resistance to Neoadjuvant Chemotherapy in Triple-Negative Breast Cancer.

Benedetta Donati, Francesca Reggiani, Federica Torricelli

|Feb 25, 2023
Endogenous Extracellular Matrix Regulates the Response of Osteosarcoma 3D Spheroids to Doxorubicin.

Margherita Cortini, Francesca Macchi, Francesca Reggiani

|Jul 24, 2021
CSNK1A1, KDM2A, and LTB4R2 Are New Druggable Vulnerabilities in Lung Cancer.

Elisabetta Sauta, Francesca Reggiani, Federica Torricelli

|Feb 12, 2021
Cellular and Molecular Players in the Interplay between Adipose Tissue and Breast Cancer.

Francesca Reggiani, Paolo Falvo, Francesco Bertolini

Pageof 1